| J07BC02 |
Hepatitis A, inactivated, whole virus |
AVAXIM 160 U adult |
susp. Inj. Pre-filled syringe 0, 5 ml |
Хепатит А вирус, щам GBM, инактивиран и адсорбиран ….. 160 единици |
ml |
1 |
Sanofi Pasteur S.A., Франция |
|
- |
43.42 |
|
43.42 |
100% |
|
Съгласно РУ |
НСР-4245/30.07.2014; НСР-9461/01.06.2016 |
02.07.2016 |
|
Заличен |
1718 |
| J07BC02 |
Hepatitis A, inactivated, whole virus |
AVAXIM 80 U pediatric |
susp. Inj. Pre-filled syringe 0, 5 ml |
Inactivated Hepatitis A virus / (strain GMB) / 80 U |
ml |
1 |
Sanofi Pasteur S.A., Франция |
|
ml |
29 |
|
29 |
100% |
|
Съгласно РУ |
НСР-4439/15.08.2014; НСР-9460/01.06.2016 |
02.07.2016 |
|
Заличен |
1717 |
| J07BC20 |
Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
J07BC20 Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BC20 |
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
TWINRIX ADULT |
Suspension for injection |
1ml |
ml (1 dose = 1 ml) |
1 pre-filled syringe + 1 separate needle |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
ml (1dose=1 ml) |
48.65 |
48.65 |
48.65 |
100% |
|
Съгласно РУ |
КЦРР-743/07.06.2012 г.; НСР-7782/28.12.2015 |
02.02.2016 |
08.09.2012 |
Активен |
129 |
| J07BC20 |
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
TWINRIX ADULT |
Suspension for injection |
20 mcg/1 ml |
1 dose=1 ml |
1 |
GlaxoSmithKline Biologicals S.A., Белгия |
1 dose=1 ml |
ml |
50.33 |
50.33 |
50.33 |
100% |
|
Съгласно РУ |
№ 86/17.06.2010; КЦРР-1641/15.11.2012. |
13.12.2012 |
08.09.2012 |
Заличен |
1244 |
| J07BD52 |
Measles, mumps and rubella vaccine, live |
J07BD52 Measles, mumps and rubella vaccine, live |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BD52 |
Measles, mumps and rubella vaccine (live) |
Priorix |
Powder and solvent for suspension for injection |
1 dose 0.5 ml |
|
1 vial with powder + 1 pre-filled syr. 0,5 ml solv + 2 separate needles |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
19.03 |
18.66 |
18.66 |
100% |
|
Съгласно РУ |
КЦРР-718/07.06.2012 г. |
16.11.2015 |
08.09.2012 |
Активен |
1234 |
| J07BD52 |
Measles, mumps and rubella vaccine (live) |
Priorix |
Powder and solvent for suspension for injection |
1 dose 0.5 ml |
|
1 vial with powder + 1 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
18.66 |
18.66 |
18.66 |
100% |
|
Съгласно РУ |
НСР-7216/15.10.2015. |
16.11.2015 |
|
Активен |
4084 |
| J07BD52 |
Measles, mumps and rubella vaccine (live) |
Priorix |
Powder and solvent for suspension for injection |
1 dose 0.5 ml |
|
100 vial with powder + 100 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
1872 |
18.66 |
1866 |
100% |
|
Съгласно РУ |
НСР-8093/17.02.2016. |
02.03.2016 |
|
Активен |
4184 |
| J07BF02 |
Poliomyelitis vaccine, (live attenuated) |
J07BF02 Poliomyelitis vaccine, (live attenuated) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BF02 |
Poliomyelitis vaccine, (live attenuated) |
POLIO SABIN (ORAL) |
Oral drops, suspension |
10 doses (1 ml) |
|
100 vial + dropper applicator |
ГлаксоСмитКлайн ЕООД, България |
1 |
dose |
798.24 |
0.79824 |
798.24 |
100% |
|
Съгласно РУ |
№ 25/03.08.2009. |
|
08.09.2012 |
Активен |
687 |
| J07BF03 |
Poliomyelitis vaccine, inactivated |
J07BF03 Poliomyelitis vaccine, inactivated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BF03 |
Poliomyelitis vaccine, inactivated |
Poliorix |
Solution for injection |
0.5ml (1dose) |
|
1 vial |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
17.46 |
17.46 |
17.46 |
100% |
|
Съгласно РУ |
|
|
08.09.2012 |
Активен |
128 |
| J07BH01 |
Rotavirus vaccine, live |
J07BH01 Rotavirus vaccine, live |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BH01 |
Rota virus, live attenuated |
Rotarix |
Powder and solvent for oral suspension |
Human rotavirus RIX4414 strain (live, attenuated) ≥ 106.0 CCID50 |
mg |
1 |
GlaxoSmithKline Biologicals S.A., Белгия |
|
- |
122.04 |
|
122.04 |
100% |
|
Съгласно РУ |
|
|
08.09.2012 |
Заличен |
135 |
| J07BH01 |
Rotavirus vaccine, live |
J07BH01 Rotavirus vaccine, live |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BH01 |
Rota virus, live attenuated |
ROTARIX |
Oral suspension |
1,5 ml prefilled oral applicator (glass) |
|
1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
103.73 |
103.73 |
103.73 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011; НСР-4593/15.09.2014; НСР-6181/08.05.2015 |
02.06.2015 |
08.09.2012 |
Активен |
3932 |
| J07BM01 |
(Human papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)) Адсорбирана ваксина срещу човешки папиломавирус [Тип 6, 11, 16, 18] (рекомбинанта) |
J07BM01 (Human papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)) Адсорбирана ваксина срещу човешки папиломавирус [Тип 6, 11, 16, 18] (рекомбинанта) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BM01 |
Papillomavirus (human types 6, 11, 16, 18) |
SILGARD |
Suspension for injection |
0,5 ml |
|
1 pre-filled syringe + 2 needles |
Merck Sharp & Dohme Ltd., Обединено Кралство |
1 |
dose |
211.62 |
211.62 |
211.62 |
100% |
|
Съгласно РУ |
№ 14/19.06.2009 г.; КЦРР-742/07.06.2012 г.; КЦРР-1735/04.12.2012 г |
04.01.2013 |
08.09.2012 |
Активен |
1501 |
| J07BM02 |
Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) |
J07BM02 Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BM02 |
Papillomavirus (Human Types 16, 18) |
Cervarix |
Suspension for injection |
1 dose (0,5 ml) |
|
1 pre-filled syringe + 2 needles |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
110.94 |
110.94 |
110.94 |
100% |
|
Съгласно РУ |
КЦРР-1734/04.12.2012 г; НСР-3176/07.04.2014 |
02.05.2014 |
08.09.2012 |
Активен |
2683 |
| J07CA02 |
Diphteria, tetanus, pertussis (acellular, component) and Poliomyelitis (inactivated) vaccine (adsorbed) |
J07CA02 Diphteria, tetanus, pertussis (acellular, component) and Poliomyelitis (inactivated) vaccine (adsorbed) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07CA02 |
diphtheria-pertussis-poliomyelitis-tetanus |
Boostrix polio |
Suspension for injection |
1 dose(0,5 ml) |
|
1 pre-filled syringe + 1 needle |
ГлаксоСмитКлайн ЕООД, България |
1 |
dose |
42.06 |
42.06 |
42.06 |
100% |
|
Съгласно РУ |
КЦРР-1673/20.11.2012 г.; НСР-2753/17.02.2014; НСР-5459/16.01.2015 |
16.02.2015 |
|
Активен |
3515 |
| J07CA06 |
Diphteria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilis type b conjugate vaccine (adsorbed) |
J07CA06 Diphteria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilis type b conjugate vaccine (adsorbed) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07CA06 |
diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus |
Infanrix-IPV+HIB |
Powder and suspension for suspension for injection |
|
|
1 vial + 1 pre-filled syringe 0.5 ml + 2 needles |
ГлаксоСмитКлайн ЕООД, България |
1 |
dose |
45.91 |
45.91 |
45.91 |
100% |
|
Съгласно РУ |
№ 44/07.01.2010 г.; № 57/05.03.2010 г.; КЦРР-2541/14.03.2013 г.; НСР-4994/05.11.2014; НСР-6674/09.07.2015; НСР-8326/26.02.2016 |
02.04.2016 |
08.09.2012 |
Активен |
3339 |
